β-Arrestin-Biased Angiotensin II Receptor Agonists for COVID-19.
Publication
, Journal Article
Manglik, A; Wingler, LM; Rockman, HA; Lefkowitz, RJ
Published in: Circulation
July 28, 2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
July 28, 2020
Volume
142
Issue
4
Start / End Page
318 / 320
Location
United States
Related Subject Headings
- beta-Arrestins
- SARS-CoV-2
- Pneumonia, Viral
- Pandemics
- Humans
- Drug Repositioning
- Coronavirus Infections
- Cardiovascular System & Hematology
- COVID-19
- Betacoronavirus
Citation
APA
Chicago
ICMJE
MLA
NLM
Manglik, A., Wingler, L. M., Rockman, H. A., & Lefkowitz, R. J. (2020). β-Arrestin-Biased Angiotensin II Receptor Agonists for COVID-19. Circulation, 142(4), 318–320. https://doi.org/10.1161/CIRCULATIONAHA.120.048723
Manglik, Aashish, Laura M. Wingler, Howard A. Rockman, and Robert J. Lefkowitz. “β-Arrestin-Biased Angiotensin II Receptor Agonists for COVID-19.” Circulation 142, no. 4 (July 28, 2020): 318–20. https://doi.org/10.1161/CIRCULATIONAHA.120.048723.
Manglik A, Wingler LM, Rockman HA, Lefkowitz RJ. β-Arrestin-Biased Angiotensin II Receptor Agonists for COVID-19. Circulation. 2020 Jul 28;142(4):318–20.
Manglik, Aashish, et al. “β-Arrestin-Biased Angiotensin II Receptor Agonists for COVID-19.” Circulation, vol. 142, no. 4, July 2020, pp. 318–20. Pubmed, doi:10.1161/CIRCULATIONAHA.120.048723.
Manglik A, Wingler LM, Rockman HA, Lefkowitz RJ. β-Arrestin-Biased Angiotensin II Receptor Agonists for COVID-19. Circulation. 2020 Jul 28;142(4):318–320.
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
July 28, 2020
Volume
142
Issue
4
Start / End Page
318 / 320
Location
United States
Related Subject Headings
- beta-Arrestins
- SARS-CoV-2
- Pneumonia, Viral
- Pandemics
- Humans
- Drug Repositioning
- Coronavirus Infections
- Cardiovascular System & Hematology
- COVID-19
- Betacoronavirus